Free Trial

Allianz SE Has $9.45 Million Holdings in Colgate-Palmolive Company (NYSE:CL)

Colgate-Palmolive logo with Consumer Staples background

Key Points

  • Allianz SE increased its stake in Colgate-Palmolive Company by 6.0%, holding 100,891 shares worth approximately $9.45 million as of its latest SEC filing.
  • Colgate-Palmolive reported $0.92 earnings per share for the last quarter, surpassing analysts' expectations of $0.89 and achieving a 1.0% revenue increase year-over-year.
  • The company announced a quarterly dividend of $0.52, reflecting an annual dividend yield of 2.5% and a payout ratio of 58.76%.
  • Five stocks to consider instead of Colgate-Palmolive.

Allianz SE raised its stake in Colgate-Palmolive Company (NYSE:CL - Free Report) by 6.0% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 100,891 shares of the company's stock after purchasing an additional 5,676 shares during the period. Allianz SE's holdings in Colgate-Palmolive were worth $9,453,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. Westend Capital Management LLC boosted its holdings in Colgate-Palmolive by 111.1% in the 1st quarter. Westend Capital Management LLC now owns 266 shares of the company's stock valued at $25,000 after purchasing an additional 140 shares during the period. Cornerstone Planning Group LLC boosted its holdings in Colgate-Palmolive by 1,913.3% in the 1st quarter. Cornerstone Planning Group LLC now owns 302 shares of the company's stock valued at $28,000 after purchasing an additional 287 shares during the period. Vermillion Wealth Management Inc. bought a new stake in Colgate-Palmolive in the 4th quarter valued at $31,000. Accredited Wealth Management LLC bought a new stake in Colgate-Palmolive in the 4th quarter valued at $34,000. Finally, Bernard Wealth Management Corp. bought a new stake in Colgate-Palmolive in the 4th quarter valued at $33,000. 80.41% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several research analysts recently commented on the company. Citigroup raised their target price on Colgate-Palmolive from $103.00 to $108.00 and gave the stock a "buy" rating in a research report on Monday, April 28th. Barclays raised their target price on Colgate-Palmolive from $86.00 to $87.00 and gave the stock an "equal weight" rating in a research report on Tuesday, July 15th. Wall Street Zen cut Colgate-Palmolive from a "buy" rating to a "hold" rating in a research report on Wednesday, May 7th. JPMorgan Chase & Co. reduced their target price on Colgate-Palmolive from $103.00 to $99.00 and set an "overweight" rating for the company in a research report on Friday, July 25th. Finally, UBS Group reduced their target price on Colgate-Palmolive from $109.00 to $106.00 and set a "buy" rating for the company in a research report on Thursday, July 17th. One analyst has rated the stock with a sell rating, five have given a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Hold" and an average target price of $100.58.

Get Our Latest Research Report on CL

Colgate-Palmolive Stock Down 0.4%

Shares of NYSE CL opened at $83.51 on Friday. Colgate-Palmolive Company has a 52-week low of $82.70 and a 52-week high of $109.30. The stock has a market cap of $67.68 billion, a PE ratio of 23.46, a PEG ratio of 4.31 and a beta of 0.35. The company has a debt-to-equity ratio of 8.96, a quick ratio of 0.54 and a current ratio of 0.85. The business has a fifty day moving average of $89.59 and a two-hundred day moving average of $90.30.

Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its earnings results on Friday, August 1st. The company reported $0.92 earnings per share for the quarter, beating analysts' consensus estimates of $0.89 by $0.03. Colgate-Palmolive had a return on equity of 461.04% and a net margin of 14.52%. The company had revenue of $5.11 billion during the quarter, compared to analyst estimates of $5.03 billion. During the same period last year, the company posted $0.91 earnings per share. The firm's quarterly revenue was up 1.0% compared to the same quarter last year. As a group, equities research analysts expect that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 15th. Stockholders of record on Friday, July 18th will be paid a $0.52 dividend. The ex-dividend date is Friday, July 18th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.5%. Colgate-Palmolive's dividend payout ratio (DPR) is 58.76%.

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Read More

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL - Free Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Colgate-Palmolive Right Now?

Before you consider Colgate-Palmolive, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.

While Colgate-Palmolive currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir & AMD Earnings: Massive Options Setups Ahead
3 Value Plays Set to Explode
5 Stocks to BUY NOW in August 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines